Prognostic factors and related complications/sequalae of squamous cell carcinoma located in the gingivobuccal complex

Yunhao Zhu, Bo Li, Huan Liu, Delong Li, Aoming Cheng, Chong Wang, Zhengxue Han, Zhien Feng, Yunhao Zhu, Bo Li, Huan Liu, Delong Li, Aoming Cheng, Chong Wang, Zhengxue Han, Zhien Feng

Abstract

Background: Gingivobuccal complex (GBC) was a relatively new concept of oral subsite that was comprises of the upper and/or lower gingiva, gingival buccal sulcus, and adjacent buccal mucosa. Squamous cell carcinoma (SCC) of the GBC had a poor prognosis, with few studies analyzing this particular entity. The objective of this study was to analyze the risk factors affecting the prognosis and complications/sequalae of gingivobuccal complex cancer.

Methods: Between December 2014 and August 2019, a total of 122 patients diagnosed with primary gingivobuccal complex cancer in Beijing Stomatological Hospital, Capital Medical University were enrolled in the study. Through outpatient reviewed and telephone followed-up for 2-5 years postoperatively, postoperative relapse and complications/sequalae were assessed. The primary outcome parameter was 2-year disease-free survival.

Results: The most common central site of the tumor was the buccal mucosa (45.1%), followed by the lower gingiva (36.9%). The most diseases were pT4a (45.1%) and there was lymph node invasion (pN+) in 41.8% of patients. Moderate differentiated squamous carcinoma (77.9%) accounted for the vast majority of the histopathological differentiation. A total of 62.3% of tumors invaded the bone, while, 5.7% invaded the skin layer. Survival analysis found that 44.3% of patients experienced relapse within two years postoperatively and the mortality rate after relapse was 75.9%. Almost 60.0% of the tumors involving the maxilla and/or mandible developed relapse. Cox proportional hazards model found that pN stage (p= 0.002) and bone invasion (p= 0.007) were significant independent predictors of 2-year disease-free survival. Importantly, 63.1% of patients had postoperative (and postradiotherapy) complications/sequalae. It was noteworthy that 18 of 43 patients (41.9%) who implanted with titanium plates had hardware-related complications/sequalae, and the most of them were titanium plate exposure (61.1%).

Conclusions: Squamous cell carcinoma of the gingivobuccal complex cancer, as a new subsite worthy of attention in oral cancer, has a high complication/sequalae rate, high relapse rate and poor prognosis.

Trial registration: Prospective, Observational, Real-world Oral Malignant Tumors Study ( clinicaltrials.gov identifier: NCT02395367). The approval of the Institutional Review Board of the Beijing Stomatological Hospital of Capital Medical University (Approval number: CMUSH-IRB-KJPJ-2015-08).

Keywords: Bone invasion; Gingivobuccal complex cancer; Hardware-related complication; Oral squamous cell carcinoma; Sequalae.

Conflict of interest statement

The authors declare that they have no conflicts of interest to this work.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Typical primary tumor of GBC cancer (A); The defect after en bloc resection of the primary tumor and neck lymph tissue (B); Specimens of primary tumor and neck dissection (C); Reconstruction using a free fibula flap and rigid internal fixation (the arrow shows that only the skin and subcutaneous tissue will cover the surface of the fibular flap and the reconstructed titanium plate, and the platysma and buccal muscles have been removed) (D); Profile image at one week postoperatively (the arrow shows that only the thin layer of skin and subcutaneous tissue was wrapped on the outside of the titanium plate) (E); Orthopantomography one week postoperatively (F)
Fig. 2
Fig. 2
K-M curves drawn by dividing pathological T stage into early (pT1 and pT2) and late (pT3 and pT4) stages (A); K-M curves drawn by dividing pathological N stage into pN0 and pN+ (pN1, pN2 and pN3) (B)
Fig. 3
Fig. 3
K-M curves comparing whether the jaw was involved

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492.
    1. Batta N, Pandey M. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance. World J Surg Oncol. 2019;17(1):198. doi: 10.1186/s12957-019-1741-2.
    1. Pillai J, Chincholkar T, Dixit R, Pandey M. A systematic review of proteomic biomarkers in oral squamous cell cancer. World J Surg Oncol. 2021;19(1):315. doi: 10.1186/s12957-021-02423-y.
    1. Diaz EM, Jr, Holsinger FC, Zuniga ER, Roberts DB, Sorensen DM. Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients. Head Neck. 2003;25(4):267–273. doi: 10.1002/hed.10221.
    1. Walvekar RR, Chaukar DA, Deshpande MS, Pai PS, Chaturvedi P, Kakade A, et al. Squamous cell carcinoma of the gingivobuccal complex: predictors of locoregional failure in stage III-IV cancers. Oral Oncol. 2009;45(2):135–140. doi: 10.1016/j.oraloncology.2008.04.007.
    1. Chen YJ, Chang JT, Liao CT, Wang HM, Yen TC, Chiu CC, et al. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci. 2008;99(8):1507–1514. doi: 10.1111/j.1349-7006.2008.00863.x.
    1. Pathak KA, Gupta S, Talole S, Khanna V, Chaturvedi P, Deshpande MS, et al. Advanced squamous cell carcinoma of lower gingivobuccal complex: patterns of spread and failure. Head Neck. 2005;27(7):597–602. doi: 10.1002/hed.20195.
    1. Rao RS, Deshmane VH, Parikh HK, Parikh DM, Sukthankar PS. Extent of lymph node dissection in T3/T4 cancer of the alveolo-buccal complex. Head Neck. 1995;17(3):199–203. doi: 10.1002/hed.2880170306.
    1. Pradhan SA, D'Cruz AK, Gulla RI. What is optimum neck dissection for T3/4 buccal-gingival cancers? Eur Arch Otorhinolaryngol. 1995;252(3):143–145. doi: 10.1007/BF00178100.
    1. Bede SYH, Ismael WK, Hashim EA. Reconstruction plate-related complications in mandibular continuity defects. Oral Maxillofac Surgery. 2019;23(2):193–199. doi: 10.1007/s10006-019-00762-5.
    1. Feng Z, Wang C, Li B, Kim K, Li J, Mao M, et al. A pilot study of modified resection for anterior floor of the mouth squamous cell carcinoma without infiltration of the mandible. J Craniomaxillofac Surg. 2019;47(3):516–522. doi: 10.1016/j.jcms.2018.11.019.
    1. Ringash J. Survivorship and Quality of Life in Head and Neck Cancer. J Clin Oncol. 2015;33(29):3322–3327. doi: 10.1200/JCO.2015.61.4115.
    1. Feng Z, Niu LX, Yuan Y, Peng X, Guo CB. Risk factors and treatment of contralateral neck recurrence for unilateral oral squamous cell carcinoma: a retrospective study of 1482 cases. Oral Oncol. 2014;50(11):1081–1088. doi: 10.1016/j.oraloncology.2014.08.003.
    1. Misra S, Chaturvedi A, Misra NC. Management of gingivobuccal complex cancer. Ann R Coll Surg Engl. 2008;90(7):546–553. doi: 10.1308/003588408X301136.
    1. Rendenbach C, Steffen C, Hanken H, Schluermann K, Henningsen A, Beck-Broichsitter B, et al. Complication rates and clinical outcomes of osseous free flaps: a retrospective comparison of CAD/CAM versus conventional fixation in 128 patients. Int J Oral Maxillofac Surg. 2019;48(9):1156–1162. doi: 10.1016/j.ijom.2019.01.029.
    1. Muñoz Guerra MF, Naval Gías L, Campo FR, Pérez JS. Marginal and segmental mandibulectomy in patients with oral cancer: a statistical analysis of 106 cases. J Oral Maxillofac Surg. 2003;61(11):1289–1296. doi: 10.1016/S0278-2391(03)00730-4.
    1. Pradhan SA. Surgery for cancer of the buccal mucosa. Sem Surg Oncol. 1989;5(5):318–321. doi: 10.1002/ssu.2980050505.
    1. Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tomoyose T, Tanaka T, et al. The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med. 2005;34(6):329–333. doi: 10.1111/j.1600-0714.2005.00244.x.
    1. Willén R, Nathanson A, Moberger G, Anneroth G. Squamous cell carcinoma of the gingiva. Histological classification and grading of malignancy. Acta Otolaryngol. 1975;79(1-2):146–154. doi: 10.3109/00016487509124667.
    1. Holm LE, Lundquist PG, Silfverswärd C, Sobin A. Histological grading of malignancy in squamous cell carcinoma of the oral tongue. Acta Otolaryngol. 1982;94(1-2):185–192. doi: 10.3109/00016488209128904.
    1. Fang FM, Leung SW, Huang CC, Liu YT, Wang CJ, Chen HC, et al. Combined-modality therapy for squamous carcinoma of the buccal mucosa: treatment results and prognostic factors. Head Neck. 1997;19(6):506–512. doi: 10.1002/(SICI)1097-0347(199709)19:6<506::AID-HED8>;2-2.
    1. Morris LG, Patel SG, Shah JP, Ganly I. High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus. Head Neck. 2011;33(6):824–830. doi: 10.1002/hed.21547.
    1. Lin HW, Bhattacharyya N. Survival impact of nodal disease in hard palate and maxillary alveolus cancer. Laryngoscope. 2009;119(2):312–315. doi: 10.1002/lary.20054.
    1. Mourouzis C, Pratt C, Brennan PA. Squamous cell carcinoma of the maxillary gingiva, alveolus, and hard palate: is there a need for elective neck dissection? Br J Oral Maxillofac Surg. 2010;48(5):345–348. doi: 10.1016/j.bjoms.2009.07.012.
    1. Feng Z, Li JN, Li CZ, Guo CB. Elective neck dissection versus observation for cN0 neck of squamous cell carcinoma primarily located in the maxillary gingiva and alveolar ridge: a retrospective study of 129 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(5):556–561. doi: 10.1016/j.oooo.2013.07.011.
    1. Yang X, Song X, Chu W, Li L, Ma L, Wu Y. Clinicopathological Characteristics and Outcome Predictors in Squamous Cell Carcinoma of the Maxillary Gingiva and Hard Palate. J Oral Maxillofac Surg. 2015;73(7):1429–1436. doi: 10.1016/j.joms.2014.12.034.
    1. Odenthal J, Takes R, Friedl P. Plasticity of tumor cell invasion: governance by growth factors and cytokines. Carcinogenesis. 2016;37(12):1117–1128.
    1. Woolgar JA, Triantafyllou A. A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens. Oral Oncol. 2005;41(10):1034–1043. doi: 10.1016/j.oraloncology.2005.06.008.
    1. Umeda M, Shigeta T, Takahashi H, Kataoka T, Oguni A, Minamikawa T, et al. Metastasis to the lateral retropharyngeal lymph node from squamous cell carcinoma of the oral cavity: report of three cases. Int J Oral Maxillofac Surg. 2009;38(9):1004–1008. doi: 10.1016/j.ijom.2009.04.015.
    1. Barttelbort SW, Ariyan S. Mandible preservation with oral cavity carcinoma: rim mandibulectomy versus sagittal mandibulectomy. Am J Surg. 1993;166(4):411–415. doi: 10.1016/S0002-9610(05)80344-7.
    1. Okuyama K, Michi Y, Mizutani M, Yamashiro M, Kaida A, Harada K. Clinical study on mandibular fracture after marginal resection of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(5):461–467. doi: 10.1016/j.oooo.2015.11.003.
    1. Yao CM, Ziai H, Tsang G, Copeland A, Brown D, Irish JC, et al. Surgical site infections following oral cavity cancer resection and reconstruction is a risk factor for plate exposure. J Otolaryngol Head Neck Surg = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale. 2017;46(1):30.
    1. Nicholson RE, Schuller DE, Forrest LA, Mountain RE, Ali T, Young D. Factors involved in long- and short-term mandibular plate exposure. Arch Otolaryngol Head Neck Surg. 1997;123(2):217–222. doi: 10.1001/archotol.1997.01900020107016.
    1. Boyd TG, Huber KM, Verbist DE, Bumpous JM, Wilhelmi BJ. CASE REPORT Removal of Exposed Titanium Reconstruction Plate After Mandibular Reconstruction With a Free Fibula Osteocutaneous Flap With Large Surgical Pin Cutters: A Case Report and Literature Review. Eplasty. 2012;12:e42.
    1. Ryu JK, Stern RL, Robinson MG, Bowers MK, Kubo HD, Donald PJ, et al. Mandibular reconstruction using a titanium plate: the impact of radiation therapy on plate preservation. Int J Radiat Oncol Biol Phys. 1995;32(3):627–634. doi: 10.1016/0360-3016(95)00074-9.
    1. Terkawi AS, Tsang S, Alshehri AS, Mulafikh DS, Alghulikah AA, AlDhahri SF. The burden of chronic pain after major head and neck tumor therapy. Saudi J Anaesth. 2017;11(Suppl 1):S71–Ss9. doi: 10.4103/sja.SJA_162_17.
    1. Göransson H, Leppänen OV, Vastamäki M. Patient outcome after surgical management of the spinal accessory nerve injury: A long-term follow-up study. SAGE Open Med. 2016;4:2050312116645731. doi: 10.1177/2050312116645731.
    1. Hamner JB, Fleming MD. Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer. Ann Surg Oncol. 2007;14(6):1904–1908. doi: 10.1245/s10434-006-9332-1.
    1. Poglio S, Galvani S, Bour S, André M, Prunet-Marcassus B, Pénicaud L, et al. Adipose tissue sensitivity to radiation exposure. Am J Pathol. 2009;174(1):44–53. doi: 10.2353/ajpath.2009.080505.

Source: PubMed

3
Iratkozz fel